BNGOBionano Genomics, Inc.
1.250USD+0.51%Mkt Cap: 14.34M USDP/E: Last update: 2026-06-01

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers …

Indicators:|

Key Statistics

Company
Market Cap14.34M USD
Enterprise Value16.84M USD
Revenue (TTM)28.74M USD
Gross Profit13.19M USD
Net Income (TTM)-26.39M USD
Revenue/Share3.823 USD
Last Price1.250 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees95
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.12
PEG
EV/EBITDA-0.72
EV/Revenue0.59
P/S0.50
P/B0.37
EPS (TTM)-4.46
EPS (Forward)-1.11
52W Range
1.0604% of range5.500
52W High5.500 USD
52W Low1.060 USD
Profitability
Gross Margin46.25%
Oper. Margin-118.09%
EBITDA Margin-81.31%
Profit Margin-92.59%
ROE-59.42%
ROA-35.87%
Growth
Revenue Growth3.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-16.34M USD
CapEx (TTM)
FCF Margin-19.95%
FCF Yield-39.98%
Net Debt2.61M USD
Net Debt/EBITDA-0.11
Balance Sheet
Debt/Equity0.16
Current Ratio1.84
Quick Ratio0.87
Book Value/Sh3.322 USD
Cash/Share1.255 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:60
Split DateJan 27, 2025
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)5.000 USD
Target Range4.000 USD6.000 USD
# Analysts2
Ownership
Shares Out.11.47M
Float10.30M
Insiders7.40%
Institutions10.12%
Short Interest
Short Ratio8.0d
Short % Float10.67%
Short % Out.10.67%
Shares Short1.22M
Short (prev mo.)1.15M
Technical
SMA 501.213 (+3.1%)
SMA 2001.734 (-27.9%)
Beta
S&P 52W Chg27.94%
Avg Vol (30d)151.05K
Avg Vol (10d)176.04K
Technical Indicators
RSI (14)52.9
MACD0.0059
MACD Signal0.0038
MACD Hist.+0.0021
BB Upper1.324 USD
BB Middle1.234 USD
BB Lower1.145 USD
BB Width14.53%
ATR (14)0.0602 USD
Vol Ratio (20d)0.95x